Publications:

bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti-angiogenic agent apatinib combination therapy.

Clinical And Translational Medicine

Xu, Gehan G; Cui, Liang L; Li, Jin J; Wang, Quanren Q; Li, Pansong P; Xia, Xuefeng X; Yi, Xin X; Guan, Quanlin Q; Xu, Jianming J

Publication Date: 2022-10

Variant appearance in text: TERT: 1142G>A; Arg381His

PubMed Link: 36245284

Variant Present in the following documents:

• CTM2-12-e1086-s010.xlsx, sheet 4

View BVdb publication page

Detection of KRAS mutations in plasma cell-free DNA of colorectal cancer patients and comparison with cancer panel data for tissue samples of the same cancers.

Genomics & Informatics

Min, Suji S; Shin, Sun S; Chung, Yeun-Jun YJ

Publication Date: 2019-12

Variant appearance in text: TERT: R381H

PubMed Link: 31896242

Variant Present in the following documents:

• Main text
• gi-2019-17-4-e42.pdf

View BVdb publication page